- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01993693
Wearable Therapeutic Ultrasound Study for Knee Osteoarthritis
Wearable Therapeutic Ultrasound Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Up to 50 million people in the U.S. suffer from some form of chronic pain, and 60% of these Americans are under 65 and have limited mobility because of knee or hip Osteoarthritis (OA). Pharmaceuticals currently dominate the treatment options due to widespread insurance coverage and convenience. However, there are a myriad of public health problems associated with analgesic use, including costs, untoward side effects, and addiction potential with opioid analgesics.
Ultrasound therapy for pain and healing has been approved by the U.S. FDA and has been in use around the globe for the last 60 years. Traditionally, ultrasound-mediated pain treatment has been delivered in clinics and has been limited to short and confined periods of 5-15 min at acoustic intensities from 1-4 W/cm2 over a course of weeks to months. Over the past decade, research has increasingly focused on lower-intensity therapeutic ultrasound (30-1000 mW/cm2) delivered over extended 1-8 hr periods. (mW = milliwatt) Recent animal studies using low-intensity therapeutic ultrasound (LITUS) have demonstrated successful inflammation reduction, reduced cartilage degeneration, and tendon and fracture healing. It is believed that using a lower-intensity ultrasonic treatment regimen over extended treatment periods works with the body's natural healing process and minimizes acoustic insult as compared with traditional, higher intensity treatments. This study proposes to evaluate clinically the first wearable low intensity ultrasound system for noninvasive treatment of arthritis pain. This technology has the potential to measurably increase the quality of life for millions of people who suffer from osteoarthritis pain by providing a safe, effective, and easy-to-use treatment.
The pilot study will test the versatile ultrasound therapy system in a clinical study that will enroll up to 60 patients with mobility-impairing knee OA. The goal of the study is to establish statistically significant data that daily 4 hour LITUS treatment decreases participant pain (Visual Analog Scale [VAS]) and improves patient mobility (measured by an accelerometer worn by each participant) over placebo devices.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
East Syracuse, New York, United States, 13057
- Upstate Orthopedics
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Individual will be included if they:
- Have physician-diagnosed mild to moderate knee OA (OARSI atlas grades 1-2) based on fixed-flexion x-ray radiological findings for osteophytes and joint space narrowing within the past 12 months,
- are between 35-65 years of age
- report a frequent pain score between 4-7 (range: 0-10) during the week preceding enrollment
- report mobility limitations because of their knee pain
- are currently not taking any prescription pain medication other than nonsteroidal antiinflammatory drugs (NSAIDs). All pain medication taken during the study should be documented.
- are willing not to use any cream, gel, or topical solution during the administration of treatment other than the approved ultrasound gel provided to the subject at the initiation of the study
- are deemed appropriate by their physician to participate.
Individuals will be excluded if they:
- cannot successfully demonstrate the ability to put on and take off the device
- are cognitively impaired
- have bone-on-bone crepitus
- have severe OA or patients with little to no cartilage on the knee
- have knee replacement or other surgical intervention
- take variable prescription medication
- are non-ambulatory
- participated in a clinical trial for an investigational drug and/or agent within 30 days prior to screening
- are currently taking neuropathic medications (ie: Neurontin, Lyrica or Topamax) and/or antidepressants (ie: Amitriptyline).
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Ultrasonic Diathermy Device
Therapeutic ultrasound used daily.
|
The Ultrasonic Diathermy Device provides low intensity therapeutic ultrasound to musculoskeletal tissues and joints for the purpose of pain relief, relief of muscle spasm, treatment of joint contraction, and local increase of circulation.
The device is FDA-cleared for up to 4 hours of continuous use per treatment.
It is a stationary hands-free device.
Other Names:
|
Placebo Comparator: Sham Ultrasonic Diathermy Device
Sham device that does not deliver ultrasound
|
Sham therapy delivered by Ultrasonic Diathermy Device that appears identical to active device but does not deliver ultrasound
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain
Time Frame: Pain will be recorded twice a day, immediately before application of the device and then immediately after the 4 hour treatment.
|
Pain will be recorded using the Visual Analogue Scale (VAS).
|
Pain will be recorded twice a day, immediately before application of the device and then immediately after the 4 hour treatment.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Mobility
Time Frame: Mobility will be recorded logged every 5 minutes, up to 24 hours a day, by the actigraph that the subject is wearing on their wrist.
|
Mobility will be measured using an actigraph that will be worn on the subject's wrist 24 hours a day.
|
Mobility will be recorded logged every 5 minutes, up to 24 hours a day, by the actigraph that the subject is wearing on their wrist.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Timothy A. Damron, MD, SUNY Upstate Orthopedics
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- OA-02
- 2012-1 (SUNY Upstate IRB (Upstate Medical University))
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Knee Osteoarthritis
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
University Hospital, Clermont-FerrandSanofiCompletedKnee Osteoarthritis (Knee OA)France
-
Joseph E. BroylesCompletedDegenerative Lesion of Articular Cartilage of Knee | Degeneration; Articular Cartilage, Knee | Unilateral Primary Osteoarthritis of Knee | Osteoarthritis Knee
-
The Hong Kong Polytechnic UniversityCompleted
-
Federal University of São PauloCompletedKNEE OSTEOARTHRITISBrazil
-
Jiangsu XinChen-Techfields Pharma Co., LTD.Completed
-
Tianjin XinChen-Techfields Pharma Co., LTD.Completed
-
Eun Jung KimMinistry of Health & Welfare, Korea; Semyung UniversityUnknownOsteoarthritis KneeKorea, Republic of
-
Thammasat UniversityCompletedPrimary Knee OsteoarthritisThailand
-
Galderma R&DCompletedUnilateral Knee OsteoarthritisUnited Kingdom
Clinical Trials on Ultrasonic Diathermy Device
-
Universidad de GranadaCompleted
-
TheraclionActive, not recruitingBreast FibroadenomaBulgaria
-
TheraclionCompleted
-
Knut N. LeknesCompletedPeri-ImplantitisNorway
-
ZetrOZ, Inc.CompletedTendinopathy | Tendinosis | TendinitisUnited States
-
University of SienaNot yet recruitingPeriodontitis, AdultItaly
-
Rambam Health Care CampusUnknownComparison Between Ultrasound and Clinical MeasurementsIsrael
-
Inonu UniversityCompleted
-
Calvary Hospital, Bronx, NYCompleted
-
TheraclionWithdrawnEnd Stage Renal Disease | Secondary Hyperparathyroidism | Parathyroid HyperplasiaSpain, Italy